Your browser is no longer supported. Please, upgrade your browser.
Adial Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.01 Insider Own20.51% Shs Outstand19.85M Perf Week-6.32%
Market Cap56.58M Forward P/E- EPS next Y-0.72 Insider Trans0.71% Shs Float16.80M Perf Month-17.08%
Income-17.10M PEG- EPS next Q-0.17 Inst Own9.40% Short Float5.93% Perf Quarter-38.62%
Sales- P/S- EPS this Y-0.20% Inst Trans2.57% Short Ratio2.94 Perf Half Y-5.32%
Book/sh0.36 P/B7.42 EPS next Y21.60% ROA-209.20% Target Price10.67 Perf Year35.53%
Cash/sh0.34 P/C7.86 EPS next 5Y- ROE-315.50% 52W Range1.60 - 5.08 Perf YTD57.06%
Dividend- P/FCF- EPS past 5Y-47.50% ROI- 52W High-47.44% Beta0.49
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin- 52W Low66.88% ATR0.26
Employees8 Current Ratio4.10 Sales Q/Q- Oper. Margin- RSI (14)38.11 Volatility11.90% 9.35%
OptionableYes Debt/Eq0.00 EPS Q/Q11.00% Profit Margin- Rel Volume0.40 Prev Close2.68
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume338.17K Price2.67
Recom2.00 SMA20-11.31% SMA50-23.48% SMA200-9.23% Volume135,266 Change-0.37%
Oct-30-18Initiated Maxim Group Buy $5
Oct-11-18Initiated Dawson James Buy
Nov-29-21 09:00AM  
Nov-17-21 09:42AM  
Nov-10-21 09:26AM  
Nov-09-21 09:15AM  
Nov-03-21 09:10AM  
Oct-21-21 01:06PM  
Oct-18-21 09:30AM  
Oct-05-21 09:25AM  
Oct-04-21 04:30PM  
Sep-30-21 09:25AM  
Sep-28-21 09:49AM  
Sep-15-21 10:07AM  
Sep-13-21 09:30AM  
Sep-07-21 09:00AM  
Aug-31-21 09:30AM  
Aug-20-21 10:45AM  
Aug-12-21 02:50PM  
Aug-10-21 09:30AM  
Aug-05-21 10:12AM  
Jul-29-21 09:30AM  
Jul-14-21 02:00PM  
Jul-07-21 10:11AM  
Jul-06-21 09:25AM  
Jun-28-21 09:45AM  
Jun-25-21 09:02AM  
Jun-24-21 05:07PM  
Jun-22-21 09:55AM  
Jun-07-21 09:30AM  
Jun-03-21 09:54AM  
May-18-21 01:19PM  
Apr-07-21 11:09AM  
Mar-23-21 09:00AM  
Mar-17-21 10:00AM  
Mar-15-21 09:30AM  
Feb-26-21 03:05PM  
Feb-25-21 09:30AM  
Feb-23-21 01:00PM  
Jan-26-21 10:15AM  
Jan-11-21 11:00AM  
Dec-17-20 09:45AM  
Dec-15-20 09:30AM  
Dec-10-20 12:10PM  
Dec-09-20 11:25AM  
Dec-04-20 09:30AM  
Nov-25-20 12:20PM  
Nov-16-20 05:33AM  
Nov-03-20 09:50AM  
Oct-22-20 09:30AM  
Oct-21-20 09:30AM  
Sep-30-20 09:25AM  
Sep-29-20 09:30AM  
Sep-25-20 10:00AM  
Sep-22-20 09:30AM  
Sep-09-20 09:00AM  
Sep-01-20 07:22PM  
Aug-31-20 05:00PM  
Aug-06-20 09:30AM  
Aug-05-20 09:00AM  
Jul-28-20 09:30AM  
Jul-22-20 09:45AM  
Jul-06-20 08:15AM  
Jun-25-20 09:30AM  
Jun-17-20 09:55AM  
Jun-15-20 09:30AM  
Jun-11-20 11:35AM  
Jun-10-20 10:06AM  
Jun-09-20 09:15AM  
Jun-08-20 09:30AM  
May-28-20 09:30AM  
May-04-20 10:15AM  
Apr-23-20 08:45AM  
Apr-16-20 10:17AM  
Apr-15-20 09:45AM  
Apr-09-20 09:30AM  
Mar-29-20 08:19AM  
Mar-26-20 09:15AM  
Mar-17-20 09:30AM  
Feb-19-20 09:37AM  
Feb-14-20 09:15AM  
Feb-06-20 12:30PM  
Jan-09-20 09:15AM  
Dec-30-19 05:36AM  
Dec-19-19 09:30AM  
Dec-16-19 09:00AM  
Dec-13-19 09:30AM  
Oct-29-19 08:30AM  
Oct-17-19 10:30AM  
Oct-07-19 09:26AM  
Oct-01-19 08:30AM  
Sep-27-19 11:52AM  
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Charlottesville, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stilley William B. IIIChief Executive OfficerNov 30Buy2.7510,60029,179937,646Dec 01 09:25 AM
Stilley William B. IIIChief Executive OfficerNov 29Buy2.5910,00025,892927,046Dec 01 09:25 AM
Newman James W. Jr.DirectorNov 26Buy2.8510,00028,50034,475Nov 30 09:25 AM
Johnson Bankole A.Chief Medical OfficerApr 06Sale2.50150,000375,000548,336Apr 08 09:47 PM